Physician

Abdul R. Miah, MD

According to 2025 Medicare claims, Abdul Miah, MD (NPI: 1467848010) practices hematology/oncology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Iredell, NC. This provider's primary affiliated billing organization is SOUTHERN ONCOLOGY SPECIALISTS, PLLC (NPI: 1336455674; TIN: 272598523) and primary practice location at 28625-9376.

Miah's data goes back to 2015 and runs through 2024. For example, in 2022, this provider had 55 traditional Medicare patients, billed 243 HCPCS/CPT codes, and received $21,511 in Medicare payments. 2024 Part D data shows 38 prescription claims across 18 beneficiaries totaling $59,839 in drug costs. 2021 DME data shows 26 claims. Open Payments data shows 2 records totaling $128. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $26,603 to $21,511. In contrast, Part D prescription costs have moved sharply higher in recent years, from $3,071 to $59,839. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$36K$72K2018 Medicare payment: $26,603 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $72,071 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $63,966 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $42,109 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $21,511 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201862306$26,603
2019180807$72,071
2020150723$63,966
2021103487$42,109
202255243$21,511
2023N/RN/RN/R
2024N/RN/RN/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$30K$60K2015 Drug cost: $3,071 (USD; Tot_Drug_Cst)2016 Drug cost: $4,407 (USD; Tot_Drug_Cst)2017 Drug cost: $17,378 (USD; Tot_Drug_Cst)2018 Drug cost: $12,128 (USD; Tot_Drug_Cst)2019 Drug cost: $8,439 (USD; Tot_Drug_Cst)2020 Drug cost: $9,418 (USD; Tot_Drug_Cst)2021 Drug cost: $5,429 (USD; Tot_Drug_Cst)2022 Drug cost: $4,846 (USD; Tot_Drug_Cst)2023 Drug cost: $3,067 (USD; Tot_Drug_Cst)2024 Drug cost: $59,839 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152159$3,071
201642160$4,407
201764330$17,378
201842195$12,128
201959145$8,439
202048118$9,418
20213382$5,429
20222047$4,846
20231839$3,067
20241838$59,839

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$4.2K$8.4K2018 Medicare payment: $8,397 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,365 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R48$8,397
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R26$1,365
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$128Alexion Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abdul R. Miah, MD?

Tedicare shows public-source Medicare data for Abdul R. Miah, MD (NPI 1467848010), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul R. Miah, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdul R. Miah, MD?

Abdul R. Miah, MD is linked to SOUTHERN ONCOLOGY SPECIALISTS, PLLC (billing NPI 1336455674) in the available physician profile data.

Does Abdul R. Miah, MD have Open Payments data?

Abdul R. Miah, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.